ad image

Seqens

1 / 1
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
Small Molecule

The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic

Pierre Luzeau, Ph.D.

Seqens

PAP-Q4-20-CL-025Dec 09, 2020
Seqens
Investment

SEQENS Invests in New Technologies

Seqens

PR-M11-20-015Nov 19, 2020
Seqens
Leadership

Seqens CDMO North America Appoints Jean-Noel David as Managing Director

Seqens

PR-M09-20-21-1287Sep 16, 2020
Seqens

SEQENS Inaugurates HPAPI Unit

Seqens

PR-M08-20-NI-47Aug 28, 2020
Seqens
COVID-19

SEQENS Mobilizes its Innovation to Support the Unprecedented Research on COVID-19 and Prepares its Unique Industrial Network for Anti-Virus Production, for Example Hydroxychloroquine

Seqens

PR-M05-20-NI-005May 01, 2020
Evolution is Essential in the Dynamic Pharmaceutical Industry
Biopharma

Evolution is Essential in the Dynamic Pharmaceutical Industry

Ed Price

PCI Synthesis

PAP-Q1-20-CL-033Mar 19, 2020
Seqens
Generics

Seqens North America Identifies Trends Affecting the Generic Drugs Sector in 2020

Seqens

PR-M01-20-NI-021Jan 15, 2020
Seqens
Capacity Expansion

Seqens to Unveil New Innovation and Development Center of Excellence

Seqens

PR-M06-19-NI-019Jun 17, 2019
Applying Enzymatic Synthesis for Chiral Molecules
Chiral Synthesis

Applying Enzymatic Synthesis for Chiral Molecules

Juliette Martin, Ph.D.; Sergio Kreimerman, Ph.D.

Seqens

PAP-Q2-2019-CL-029May 24, 2019
Seqens
Drug Development

Glycuron™ 2.78 Able to Enhance Measurable Positive Image Perception

Seqens

PR-M04-19-NI-019Apr 01, 2019
Seqens
Probiotics

Megabiotic™-44, a Pre and Postbiotics Complex, from Lactobacillus Bulgaricus GLB44, Microorganism Able to Enhance Pore Refinement

Seqens

PR-M04-19-NI-018Apr 01, 2019
Seqens
Launch

Seqens Cosmetics, Functional Care (formerly Chemoxy), Launches ChemoxyCare® 6, 1,2- Hexanediol with Best in Class Quality Profile

Seqens

PR-M04-19-NI-017Apr 01, 2019
Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements
DCAT '19

Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements

David Alvaro, Ph.D.

Pharma's Almanac

PAO-M03-19-NI-024Mar 18, 2019
Investing in the Future of Potent Compounds
HPAPI

Investing in the Future of Potent Compounds

Frederic Desdouits

Seqens

PAP-Q1-2019-CL-028Mar 12, 2019
Q: What do you believe the role of artificial intelligence and other advanced technologies will be in driving the development of the pharmaceutical industry over the next decade?
Artificial Intelligence

Q: What do you believe the role of artificial intelligence and other advanced technologies will be in driving the development of the pharmaceutical industry over the next decade?

Pharma's Almanac

PAP-Q1-2019-NI-002Mar 12, 2019
PCI Pharma Services’ Ireland Site Prepared in Advance to Meet European Serialization Requirements
Serialization

PCI Pharma Services’ Ireland Site Prepared in Advance to Meet European Serialization Requirements

Guy Tiene

Nice Insight

PAO-M03-18-NI-008Mar 09, 2018
PCI Pharma Services
Serialization

PCI Pharma Services Announces Release of Joint White Paper with Domino on Ink Leachability in Pharmaceutical Serialization

PCI Pharma Services

PR-M09-17-NI-008Sep 20, 2017
PCI Pharma Services
Partnership

PCI Announces Further Investment in Specialized Labeling Capabilities

PCI Pharma Services

PR-M08-17-NI-011Sep 11, 2017
PCI Pharma Services
Capacity

PCI Pharma Services Announces Expansion of Cold Chain Capacity at Philadelphia Site

PCI Pharma Services

PR-M08-17-NI-010-5200Sep 06, 2017
1 / 1